Jianan Wang

机构：State Grid Corporation of China (China), Implant Sciences (United States), Netherlands Heart Registration, Molecular Devices (United Kingdom), Second Affiliated Hospital of Zhejiang University, Zhejiang University

发表论文 339 篇 · 总被引 8442 次 · h-index 46

代表论文

• Benefit–harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials (2025 · The Lancet · 被引 38)
• Integrated multi-omics analysis of single-cell and spatial transcriptomics reveals distinct hpv-associated immune microenvironment features and prognostic signatures in cervical cancer (2025 · Frontiers in Immunology · 被引 11)
• Effects of Mavacamten on Cardiac Magnetic Resonance Features in Chinese Patients With Obstructive Hypertrophic Cardiomyopathy (2025 · JACC Asia · 被引 8)
• PARylation promotes acute kidney injury via RACK1 dimerization-mediated HIF-1α degradation (2025 · Acta Pharmaceutica Sinica B · 被引 7)
• Thorough Physiological Assessment in Non-Culprit Vessels of Patients with Acute Myocardial Infarction: Is It a Required Action? (2025 · Cardiovascular Drugs and Therapy · 被引 6)
• Long-Term Outcomes After Fractional Flow Reserve vs Intravascular Ultrasound to Guide PCI (2025 · Journal of the American College of Cardiology · 被引 5)